CTI BIOPHARMA CORP Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CTI BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CTI BIOPHARMA CORP for March 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 30 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 0.49 | 10,000 | 4,941 | 1,810,133 | 1.8 M to 1.8 M (-0.55 %) |
Mar 23 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Payment of Exercise | F | 0.55 | 63,874 | 35,016 | 526,210 | 590.1 K to 526.2 K (-10.82 %) |
Mar 23 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Payment of Exercise | F | 0.55 | 46,556 | 25,522 | 622,933 | 669.5 K to 622.9 K (-6.95 %) |
Mar 23 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Payment of Exercise | F | 0.55 | 45,935 | 25,182 | 994,057 | 1 M to 994.1 K (-4.42 %) |
Mar 23 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 0.55 | 318,169 | 174,866 | 1,820,133 | 2.1 M to 1.8 M (-14.88 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.60 | 900 | 536 | 590,084 | 591 K to 590.1 K (-0.15 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.60 | 1,220 | 726 | 590,984 | 592.2 K to 591 K (-0.21 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 500 | 297 | 592,204 | 592.7 K to 592.2 K (-0.08 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 1,100 | 652 | 592,704 | 593.8 K to 592.7 K (-0.19 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 200 | 118 | 593,804 | 594 K to 593.8 K (-0.03 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 700 | 414 | 594,004 | 594.7 K to 594 K (-0.12 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 700 | 413 | 594,704 | 595.4 K to 594.7 K (-0.12 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 844 | 497 | 595,404 | 596.2 K to 595.4 K (-0.14 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 1,500 | 882 | 596,248 | 597.7 K to 596.2 K (-0.25 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 636 | 373 | 597,748 | 598.4 K to 597.7 K (-0.11 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 400 | 234 | 598,384 | 598.8 K to 598.4 K (-0.07 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 1,300 | 761 | 598,784 | 600.1 K to 598.8 K (-0.22 %) |